Background & Aims: Prednisolone is the first-line therapy for severe alcoholic hepatitis (AH). Patients with severe alcoholic hepatitis often develop severe infections that negatively impact short-term prognosis.
Methods: We performed this meta-analysis to assess the effect of corticosteroids on the occurrence of and mortality from infections in patients with severe alcoholic hepatitis. Randomized controlled trials examining the use of corticosteroids in severe alcoholic hepatitis and reporting data on infection rates and mortality were included. Random effects model was used to pool the data comparing arms with and without steroids for the occurrence of infection, 28-day mortality and cause specific mortality.
Results: Of 1062 patients (528 steroids treated) without infection at baseline from 12 studies, infection was reported in 213 (113 steroids treated) patients without differences comparing arms with and without steroids (OR: 0.98; CI: 0.49-1.94). However, frequency was higher for occurrence of fungal infections among steroid-treated patients (eight of 528 vs. one of 534; P = 0.02). Steroids provided mortality benefit at 28 days (OR: 0.55; CI: 0.34-0.90) mainly for liver failure-related death (OR: 0.46; CI: 0.24-0.87) without differences on mortality from infection (OR: 1.19; CI: 0.38-3.73) or gastrointestinal bleeding (OR: 0.90; CI: 0.43-1.87). Three of nine patients with fungal infections died, all in corticosteroid arm.
Conclusions: Corticosteroids do not increase occurrence of or mortality from bacterial infections in patients with severe alcoholic hepatitis. Further studies are needed to develop strategies of reducing the risk of fungal infection with use of steroids for patients with severe alcoholic hepatitis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/liv.12939 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Management of a Rapidly Progressing Huge Pancreatic Pseudocyst.
Cureus
February 2025
Internal Medicine, Catholic Health, Buffalo, USA.
Pancreatic pseudocysts are a complication of both acute and chronic pancreatitis that usually develop four to six weeks from the onset of pancreatitis. Alcoholic pancreatitis is the most important risk factor for developing such cysts, although non-alcoholic cases do also occur. This is the case of a 58-year-old male patient who presented to our emergency department with a two-day history of abdominal pain, nausea, vomiting, and inability to tolerate oral food and liquids.
View Article and Find Full Text PDFLow responsiveness of machine learning models to critical or deteriorating health conditions.
Commun Med (Lond)
March 2025
Department of Computer Science and Sanghani Center for AI and Data Analytics, Virginia Tech, Blacksburg, VA, USA.
Background: Machine learning (ML) based mortality prediction models can be immensely useful in intensive care units. Such a model should generate warnings to alert physicians when a patient's condition rapidly deteriorates, or their vitals are in highly abnormal ranges. Before clinical deployment, it is important to comprehensively assess a model's ability to recognize critical patient conditions.
View Article and Find Full Text PDFUnlocking the potential of THR-β agonist therapies: resmetirom's chemistry, biology, and patent insights.
Naunyn Schmiedebergs Arch Pharmacol
March 2025
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's, NMIMS, Deemed to Be University, Vile Parle West, Mumbai, Maharashtra, 400056, India.
Non-alcoholic steatohepatitis (NASH) is a severe manifestation of non-alcoholic fatty liver disease (NAFLD), which is characterized by hepatic steatosis, inflammation, and hepatocyte destruction. Newly adopted nomenclature, metabolic dysfunction-associated fatty liver disease (MAFLD), allows to signify the importance of metabolic dysfunction. For which the current treatment options are limited and often associated with adverse effects, creating a need for targeted therapies.
View Article and Find Full Text PDFA critical review of microbiome-derived metabolic functions and translational research in liver diseases.
Front Cell Infect Microbiol
March 2025
Human Cytogenetics and Stem Cell Laboratory, Department of Zoology, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab, India.
Significant changes in gut microbial composition are associated with chronic liver disease. Using preclinical models, it has been demonstrated that ethanol/alcohol-induced liver disease is transmissible through fecal microbiota transplantation (FMT). So, the survival rate of people with severe alcoholic hepatitis got better, which suggests that changes in the makeup and function of gut microbiota play a role in metabolic liver disease.
View Article and Find Full Text PDFAortic Dissection: An Unexpected Complication of Transcatheter Aortic Valve Implantation.
Cureus
February 2025
Cardiology, Unidade Local de Saúde (ULS) São João, Porto, PRT.
A 53-year-old female with a medical history of multiple cardiovascular risk factors, alcoholic chronic hepatic disease (Child-Pugh B) with thrombocytopenia, and severe calcified aortic stenosis was admitted for an elective transcatheter aortic valve implantation (TAVI). After the procedure, the patient was hypotensive and unresponsive to fluid challenge, and there was a significant difference in blood pressure between the two arms. The echocardiogram confirmed the normal position and function of the prosthetic valve but was suggestive of aortic dissection.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!